logo
2 votes
Posted by stock 490 days ago (http://www.thehindubusinessline.com)
The at-risk launch of the generic form of Tarka, an ACE inhibitor to control hypertension, by Glenmark Pharmaceuticals may get riskier, if the unfavourable verdict of the US federal jury is any
Discuss Bury Category: Market News

Comments Who Voted Related Links



Privacy